Business
Correction: Half-year Report
Feedback PLC has issued a correction to its half-year report, clarifying that the prior period EPS number was incorrect. For the six months ending November 30, 2025, revenue was £0.41 million, a slight decrease from £0.45 million in the prior year, with Bleepa contributing 89%. The EBITDA loss widened to £1.61 million from £1.43 million, attributed to increased support staff and technology costs. Cash reserves stood at £3.82 million as of November 30, 2025, providing runway through mid-2027. The company highlights operational progress including integrations into key NHS systems and successful pathway implementations, positioning it for national scale in 2026/27. Disclaimer*
About this update from Feedback Plc
[{"type":"text","content":"\n\nCorrection to the announcement number 2356T made at 07.00 on 17/02/26 (Half-year Report): The RNS included the wrong EPS number for the prior period earnings on the income statement and in the financial review.\n \nAll other information was correct, and the full amended text is shown below:\n \nFeedback plc\n \nHalf Year Results to 30 November 2025\n \nFeedback plc (AIM: FDBK, \"Feedback\" or the \"Company\"), the clinical infrastructure specialists, announces its unaudited results for the six months to 30 November 2025 (the \"Period\").\n \nOperational Highlights and Developments\n \n· Bleepa's proven, highly scalable model strongly positioned to fulfil NHS productivity requirements\n· A national business case for Bleepa was submitted as part of the Spending Review in the Spring - outcome pending\n· Integrations into eRS, PDS and GP Connect were completed (and implemented post period) - positioning Feedback for national scale\n· NSS pathway went live on Bleepa in Sussex ICS, second at scale pathway-proving Bleepa can also run cancer pathways\n· Strategic partnerships in late stage discussion ahead of at scale roll out including consulting firms for implementation, cloud providers and technology partners with supporting propositions\n· Bleepa was selected to run the UK's two national simulations of the new Neighbourhood Health Service - proving Bleepa can also run new care models\n \nFinancial Highlights\n \n· Revenue remains stable at £0.41m (H1 2025: £0.45m), of which Bleepa contributed 89%\n· EBITDA(1) loss increased to £1.61m (H1 2025: £1.43m), driven by new support team hires to deliver customer roll outs and technology costs associated with delivering our cloud solution.\n· Cash as at 30 November 2025 was £3.82m (30 Nov 2024: £7.26m, 31 May 2025: £5.95m), largely reflecting the higher costs above and our continued investment in our product. Sufficient runway through to mid-2027\n· The Company remains in a stable financial position and has been laying the groundwork ready to scale in 2026/27\n \nPost period Highlights\n \n· Continued engagement with...